Add like
Add dislike
Add to saved papers

The nasopalatine duct cyst: an analysis of the relation between clinical symptoms, cyst dimensions, and involvement of neighboring anatomical structures using cone beam computed tomography.

PURPOSE: This study evaluates the dimensions of nasopalatine duct cysts (NPDCs) and the involvement of neighboring anatomical structures using standardized limited cone beam computed tomography (CBCT) and a possible correlation to the patient's age, gender, preoperative symptoms, and postsurgical complications.

MATERIALS AND METHODS: The study included 25 patients with a confirmed histopathologic diagnosis of NPDC. Standardized measurements of NPDC dimensions were performed on sagittal, coronal, and axial CBCT sections. Maximas, minimas, mean, standard error of mean, and confidence intervals (95%) of all measurements were performed. The Kruskal-Wallis test was used to analyze group differences and to assess any association between measurements and preoperative symptoms or postoperative complications.

RESULTS: The patients' mean age was 49.5 years, and a male-to-female ratio of 2.1:1 was assessed. Mean cyst dimensions for men and for patients less than 50 years old tended to be higher, without statistical significance. The cyst dimensions had no statistically significant correlation to preoperative symptoms. Initial symptoms were present in all cases with a nasal defect, however. Most of the standardized cyst dimensions exhibited a statistically significant correlation to postoperative complications.

CONCLUSIONS: The presence or the absence of symptoms does not correlate with the dimensions of an NPDC. With progressive size of the cyst, the risk for minor postsurgical complications increases.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app